Taken together, evaluating Ang-2, NGAL, and KIM-1 in combination may improve risk stratification and provide further insights into the underlying mechanisms of AKI, particularly in cases related to rhabdomyolysis. The gene discussed is LCN2; the disease is rhabdomyolysis.